Candel Therapeutics, Inc.
Clinical trials sponsored by Candel Therapeutics, Inc., explained in plain language.
-
Engineered virus plus immunotherapy aims to outperform chemo in advanced lung cancer
Disease control Recruiting nowThis phase 3 trial tests whether a combination of an injected virus therapy (CAN-2409) and an immunotherapy drug (pembrolizumab) can help people with stage IV non-squamous non-small cell lung cancer live longer than standard chemotherapy. The virus is designed to kill tumor cells…
Phase: PHASE3 • Sponsor: Candel Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New gene therapy injection aims to boost prostate cancer radiation results
Disease control Recruiting nowThis study tests a gene therapy called aglatimagene besadenovec, given with valacyclovir, in 45 men with intermediate-risk prostate cancer who will also receive radiation. The main goal is to see how the therapy spreads in the body and to measure immune responses and tumor marker…
Phase: PHASE2 • Sponsor: Candel Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC